Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMS-D001 in moderate-to-severe plaque psoriasis
CTR20260287Phase 2Active
- Sponsor
- CMS Aesthetics
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CMS-D001 in plaque psoriasis, sponsored by CMS Aesthetics. Started Feb 2026; status: active.
02
Drugs
CMS-D001
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20260287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260287.